Champions Oncology

Champions Oncology develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The Company provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

Company Growth (employees)
Type
Public
HQ
Hackensack, US
Founded
2007
Size (employees)
79 (est)+32%
Champions Oncology was founded in 2007 and is headquartered in Hackensack, US

Key People/Management at Champions Oncology

Ronnie Morris

Ronnie Morris

Chief Executive Officer
Angela Davies

Angela Davies

Chief Medical Officer

Champions Oncology Office Locations

Champions Oncology has offices in Hackensack, Baltimore and London
Hackensack, US (HQ)
307 1 University Plaza Dr
Baltimore, US
602 855 N Wolfe St
London, GB
2 Royal College St
Show all (3)

Champions Oncology Financials and Metrics

Champions Oncology Financials

Champions Oncology's revenue was reported to be $11.2 m in FY, 2016
USD

Revenue (Q2, 2018)

5.2 m

Net income (Q2, 2018)

(94.3 k)

EBIT (Q2, 2018)

(70 k)

Market capitalization (23-Feb-2018)

37.6 m

Cash (31-Oct-2017)

660 k
Champions Oncology's current market capitalization is $37.6 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

11.6 m8.9 m11.2 m

Revenue growth, %

(23%)26%

Sales and marketing expense

3.4 m

R&D expense

4.2 m
USDQ2, 2018

Revenue

5.2 m

Sales and marketing expense

551 k

R&D expense

1.1 m

General and administrative expense

954 k
USDFY, 2014FY, 2015FY, 2016

Cash

5.9 m9.4 m

Accounts Receivable

1.3 m1.1 m1.3 m

Inventories

383 k346 k443 k

Current Assets

7.6 m10.8 m4.3 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

7.6 m5.8 m3.1 m575 k182 k6.8 m4.2 m3.3 m4.5 m4.3 m3.5 m430 k660 k

Accounts Receivable

1.5 m3.1 m925 k1.1 m1.1 m1.5 m1.9 m2.1 m1.6 m1.9 m2 m2.7 m2.6 m

Current Assets

9.3 m9.2 m4.4 m2.1 m1.5 m8.6 m6.3 m5.8 m6.4 m6.7 m6.1 m3.5 m3.5 m

PP&E

387 k421 k411 k395 k469 k445 k420 k514 k590 k561 k672 k2.1 m2 m
    USDFY, 2014FY, 2015FY, 2016

    Net Income

    (7.4 m)(13.1 m)(10.4 m)

    Depreciation and Amortization

    213 k214 k156 k

    Accounts Receivable

    (825 k)265 k(282 k)

    Accounts Payable

    (223 k)433 k482 k
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Accounts Receivable

    925 k1.1 m1.1 m1.5 m1.9 m2.1 m1.6 m1.9 m2 m

    Accounts Payable

    1.3 m1.6 m1.4 m1.4 m1.3 m1.5 m1.5 m1.2 m1.3 m
    USDY, 2017

    Revenue/Employee

    86.7 k

    Financial Leverage

    17.4 x
    Show all financial metrics

    Champions Oncology Market Value History

    Champions Oncology's Web-traffic and Trends

    Champions Oncology Online and Social Media Presence

    Champions Oncology Company Life and Culture

    You may also be interested in